Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events.
Arch Intern Med. 2002 Oct 28;162(19):2197-202. doi: 10.1001/archinte.162.19.2197.
Arch Intern Med. 2002.
PMID: 12390062